Cours RedHill Biopharma Ltd. OTC Markets
Actions
REDIF
IL0011223810
Produits pharmaceutiques
CA 2022 | 61,8 M 55,24 M | CA 2023 | 6,53 M 5,84 M | Capitalisation | 28,72 M 25,68 M |
---|---|---|---|---|---|
Résultat net 2022 | -71 M -63,46 M | Résultat net 2023 | 23 M 20,56 M | VE / CA 2022 | 1,87 x |
Dette nette 2022 | 103 M 91,81 M | Trésorerie nette 2023 | 4,4 M 3,93 M | VE / CA 2023 | 3,73 x |
PER 2022 |
-0,12
x | PER 2023 |
0,4
x | Employés | 53 |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 99% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 03/08/09 |
Ori Shilo
FOU | Founder | 58 | 03/08/09 |
Razi Ingber
DFI | Director of Finance/CFO | - | 05/01/23 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Rick Scruggs
BRD | Director/Board Member | 64 | 01/01/16 |
Shmuel Cabilly
BRD | Director/Board Member | 74 | 26/08/10 |
Director/Board Member | 80 | 03/05/10 |
Varia. 1 janv. | Capi. | |
---|---|---|
+7,89% | 101 Md | |
+8,42% | 42,18 Md | |
-13,04% | 32,26 Md | |
+80,80% | 29,79 Md | |
-10,92% | 16,06 Md | |
+1,93% | 14,45 Md | |
-6,77% | 12,01 Md | |
+177,16% | 10,71 Md | |
+4,12% | 8,89 Md |